Barnes & Noble Education Announces Preliminary Full-Year Fiscal 2025 and Year-to-Date Fiscal 2026 Unaudited Financial Results

(NYSE:BNED), Company Announces the Conclusion and Findings of Internal Investigation Releases Preliminary FY2025 and First Half 2026 Results First Day Complete Enrollment for Fall 2025 Estimated to Grow 24%* Board of Directors Pleased with Revenue Growth & Strong Improvements in Operating Results and Balance Sheet FLORHAM PARK, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) — Barnes […]

GCL Announces Fiscal Year 2026 Revenue and Gross Profit Expectations

(NASDAQ:GCL),(NASDAQ:GCLWW), SINGAPORE, Nov. 25, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today provided an update on management's expectations for financial results for the fiscal year 2026, ending March 31, 2026. The Company's anticipated results reflect its continued growth trajectory in the

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

(NASDAQ:LXRX), THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 9:00 a.m. ET and at the 8th Annual Evercore Healthcare Conference on Thursday, December 4 at

MACOM Promotes Robert Dennehy to Chief Operating Officer

(NASDAQ:MTSI), LOWELL, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced the promotion of Robert Dennehy to Chief Operating Officer (“COO”). In this role, Mr. Dennehy will continue to oversee MACOM's global operations, manufacturing, supply chain and operational strategies as the

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

(NASDAQ:TLSA), BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted for inclusion in the ALS MyMatch Program at the

BlackLine Issues Statement Regarding Shareholder Engagement

(NASDAQ:BL), LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) (“BlackLine” or the “Company”) today issued the following statement: The Company and members of the Board of Directors actively meet with company stockholders on a regular basis. More recently, these meetings have included Engaged Capital with whom management and independent directors have

Worksport Announces HD3 Heavy-Duty Tonneau Cover Now Selling to B2B Dealers Following October Production Launch

(NASDAQ:WKSP), Company Expands Dealer Offering with New Heavy-Duty Platform as COR and SOLIS Prepare for Initial Orders Opening November 28 West Seneca, New York, Nov. 25, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing, clean energy technologies and automotive accessories, serving both consumer and reseller

PodcastOne (Nasdaq: PODC) Aligns with Former New York Yankees Outfielder Clint Frazier for Multi-Year Exclusive Distribution Rights for Life After the Show Podcast

(NASDAQ:PODC), LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today that it has entered into a multi-year agreement with former New York Yankees outfielder Clint Frazier for the exclusive distribution rights to Frazier's Life After the Show podcast. Life After the Show episodes drop

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

(NASDAQ:IART), PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic

Reliance Global Group (RELI) Consolidates Digital Asset Treasury Into Zcash (ZEC)

(NASDAQ:RELI),(NASDAQ:RELIW), LAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed a strategic realignment of its Digital Asset Treasury (“DAT”), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prior holdings and reallocated the

Scroll to Top